64 related articles for article (PubMed ID: 11726208)
1. Growth factor regulation of the molecular chaperone calnexin.
Li F; Mandal M; Barnes CJ; Vadlamudi RK; Kumar R
Biochem Biophys Res Commun; 2001 Dec; 289(3):725-32. PubMed ID: 11726208
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells.
Vadlamudi R; Adam L; Tseng B; Costa L; Kumar R
Cancer Res; 1999 Jun; 59(12):2843-6. PubMed ID: 10383144
[TBL] [Abstract][Full Text] [Related]
3. Heregulin induces expression, DNA binding activity, and transactivating functions of basic leucine zipper activating transcription factor 4.
Talukder AH; Vadlamudi R; Mandal M; Kumar R
Cancer Res; 2000 Jan; 60(2):276-81. PubMed ID: 10667576
[TBL] [Abstract][Full Text] [Related]
4. Heregulin up-regulates heat shock protein-70 expression in breast cancer cells.
Mandal M; Li F; Kumar R
Anticancer Res; 2002; 22(4):1965-9. PubMed ID: 12174871
[TBL] [Abstract][Full Text] [Related]
5. Growth factor regulation of a 26S proteasomal subunit in breast cancer.
Barnes CJ; Li F; Talukder AH; Kumar R
Clin Cancer Res; 2005 Apr; 11(8):2868-74. PubMed ID: 15837734
[TBL] [Abstract][Full Text] [Related]
6. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
Ram TG; Schelling ME; Hosick HL
Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
[TBL] [Abstract][Full Text] [Related]
7. Heregulin regulation of autocrine motility factor expression in human tumor cells.
Talukder AH; Adam L; Raz A; Kumar R
Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603
[TBL] [Abstract][Full Text] [Related]
8. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.
Barnes CJ; Li F; Mandal M; Yang Z; Sahin AA; Kumar R
Cancer Res; 2002 Mar; 62(5):1251-5. PubMed ID: 11888885
[TBL] [Abstract][Full Text] [Related]
9. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
10. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
Menendez JA; Mehmi I; Lupu R
Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
[TBL] [Abstract][Full Text] [Related]
11. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
[TBL] [Abstract][Full Text] [Related]
12. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
Sun Y; Lin H; Zhu Y; Ma C; Ye J; Luo J
J Cell Physiol; 2002 Aug; 192(2):225-33. PubMed ID: 12115729
[TBL] [Abstract][Full Text] [Related]
13. Src family kinases and HER2 interactions in human breast cancer cell growth and survival.
Belsches-Jablonski AP; Biscardi JS; Peavy DR; Tice DA; Romney DA; Parsons SJ
Oncogene; 2001 Mar; 20(12):1465-75. PubMed ID: 11313890
[TBL] [Abstract][Full Text] [Related]
14. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
Atlas E; Cardillo M; Mehmi I; Zahedkargaran H; Tang C; Lupu R
Mol Cancer Res; 2003 Jan; 1(3):165-75. PubMed ID: 12556556
[TBL] [Abstract][Full Text] [Related]
15. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP
Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
17. The expression of the molecular chaperone calnexin is decreased in cancer cells grown as colonies compared to monolayer.
Yeates LC; Powis G
Biochem Biophys Res Commun; 1997 Sep; 238(1):66-70. PubMed ID: 9299453
[TBL] [Abstract][Full Text] [Related]
18. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
Niu G; Carter WB
Cancer Res; 2007 Feb; 67(4):1487-93. PubMed ID: 17308086
[TBL] [Abstract][Full Text] [Related]
19. Calnexin is associated with and induced by overexpressed human complement protein C2.
Tsukamoto H; Tousson A; Circolo A; Marchase RB; Volanakis JE
Anat Rec; 2002 May; 267(1):7-16. PubMed ID: 11984787
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
